NCT06624930 (BOOST-Up) is a NA clinical trial of Behavioural Counselling in Cancer, sponsored by University of Toronto.

Who is sponsoring NCT06624930?

NCT06624930 is sponsored by University of Toronto.

What drugs are being tested in NCT06624930?

Interventions in NCT06624930: Behavioural Counselling, Exercise Counselling.

What condition does NCT06624930 study?

NCT06624930 studies Cancer, Exercise.

Is NCT06624930 still recruiting?

NCT06624930 is currently recruiting now. Last updated 29 September 2025.

Last reviewed 2025-09-29 · How we verify

NCT06624930: BOOST-Up

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Behaviour Change for Cancer Survivors Trial

Recruiting now NA Last updated 29 September 2025

What this trial tests

NA trial testing Behavioural Counselling in Cancer in 236 participants. Currently enrolling.

Timeline

3 October 2024

Primary endpoint
31 May 2028

31 May 2029

Quick facts

Lead sponsor	University of Toronto
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	236
Start date	3 October 2024
Primary completion	31 May 2028
Estimated completion	31 May 2029
Sites	1 location across Canada

Drugs / interventions tested

Behavioural Counselling
Exercise Counselling

Conditions studied

Cancer — all drugs for Cancer →
Exercise — all drugs for Exercise →

Sponsor

University of Toronto

Who can join

18 and older, any sex, with Cancer or Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be a two-arm RCT, to examine the effects of an entirely virtual, 6-month supervised PA program plus standard exercise counselling (PA+EC) versus a supervised PA plus motivationally-enhanced behavioral counselling (PA+BC) on moderate to vigorous physical activity (MVPA) in cancer survivors. A 6-month post intervention follow-up (T2) and 1-year post intervention follow-up (T3; 1-year follow-up from post-intervention) will take place after the intervention to address maintenance. The intervention is designed using evidence-based research in the fields of exercise oncology using effective clinical design and theoretical approaches, including behaviour change techniques, to gradually increase MVPA to at least 90 minutes per week in cancer survivors as per the exercise guidelines for cancer survivors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A randomized controlled trial adding behavioral counseling to supervised physical activity in people living with and beyond cancer (BOOST-UP-): a study protocol for a live remotely-delivered behavior change intervention.
Trinh L, Rhodes RE, Alibhai SMH, Campbell KL, et al · · 2025 · PMID 40346460 · DOI 10.1186/s12885-025-13904-8

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Other University of Toronto trials

Trials by the same sponsor.

NCT07184255 — Animated Video Education for Retinal Surgery · NA · not yet recruiting
NCT07259434 — Time Restricted Eating in Survivors Trial 2.0 · NA · not yet recruiting
NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
NCT07268729 — Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders · not yet recruiting
NCT07317921 — Validating IAAO for Muscle Outcomes · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06624930 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Toronto
Last refreshed: 29 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06624930.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing